T. Rowe Price Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History
Bought
Maintained
Sold
Other funds holding CVET
T. Rowe Price Associates's CVET Position: Q4 2022 in Review
T. Rowe Price Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 75,142 shares — an estimated $1.57M sold.
T. Rowe Price Associates first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $256M in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.
- T. Rowe Price Associates reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 75,142 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $1.57M.
- T. Rowe Price Associates first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
- T. Rowe Price Associates's Covetrus, Inc. Common Stock position peaked at $256M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.